Clinical Trial: A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC

U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07193641) titled 'A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC' on Aug. 10.

Brief Summary: The goal of this clinical trial is to learn if spatially fractionated radiotherapy (SFRT) combined with standard systemic therapy can treat oligoprogressive non-small cell lung cancer (NSCLC) in patients who have progressed after at least one line of systemic therapy. The main question it aims to answer is:

- Can the combination of SFRT and standard systemic therapy improve progression-free survival (PFS) compared to standard systemic therapy alone?

Participants will:

* Undergo SFRT treatment for oligoprogressive lesions, with sp...